Contraception
Volume 81, Issue 6 , Pages 501-509 , June 2010

Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen

  • Cosima Brucker

      Affiliations

    • Klinikum Nürnberg Nord, Klinik für Frauenheilkunde, Prof.-Ernst-Nathan-Str. 1, 90419 Nürnberg, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 911 3982222.
  • ,
  • Bernard Hedon

      Affiliations

    • Hôpital Arnaud de Villeneuve, 371, Av. Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France
  • ,
  • Hok Sien The

      Affiliations

    • St. Antonius Ziekenhuis, Koekoekslaan 1, 3435 CM Nieuwegein, The Netherlands
  • ,
  • Kornelia Höschen

      Affiliations

    • Grünenthal GmbH, 52099 Aachen, Germany
  • ,
  • Natascha Binder

      Affiliations

    • Grünenthal GmbH, 52099 Aachen, Germany
  • ,
  • Annette Christoph

      Affiliations

    • Grünenthal GmbH, 52099 Aachen, Germany

Received 16 September 2008 ,Revised 11 January 2010 ,Accepted 13 January 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Conflict of interest statement: Professor Brucker is a member of an advisory board on 0.02 mg EE/2 mg CMA sponsored by Grünenthal GmbH, Aachen, Germany.

PII: S0010-7824(10)00012-0

doi: 10.1016/j.contraception.2010.01.011

Contraception
Volume 81, Issue 6 , Pages 501-509 , June 2010